Rapid progression of angioid streaks following   intravitreal bevacizumab.
Pratik Ranjan
PR
Sen
Pukhraj
P
Rishi
Parveen
P
Sen
Ekta
E
Rishi
Daraius
D
Shroff
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000793:Angioid Streaks / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001766:Blindness / Q000209:etiology; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D018450:Disease Progression; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008875:Middle Aged; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab